These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The preparation and validation of stock cultures of mammalian cells. Facklam TJ; Geyer S Bioprocess Technol; 1991; 13():54-85. PubMed ID: 1367151 [TBL] [Abstract][Full Text] [Related]
3. Safety aspects in biotechnology. Classifications and safety precautions for handling of biological agents. Frommer W; Krämer P Arzneimittelforschung; 1990 Jul; 40(7):837-42. PubMed ID: 2222560 [TBL] [Abstract][Full Text] [Related]
4. Training in biotechnology. Assuring worker safety through information and instruction. Van Houten J Occup Med; 1991; 6(2):169-82. PubMed ID: 2047971 [TBL] [Abstract][Full Text] [Related]
7. Promising biotechnology industry raises unique safety, health issues. Lisella FS; Herring LW Occup Health Saf; 1988 Jun; 57(6):62-3, 69-71, 81. PubMed ID: 3399236 [No Abstract] [Full Text] [Related]
8. Containment considerations for the biotechnology industry. Liberman DF; Fink R Occup Med; 1991; 6(2):271-83. PubMed ID: 2047977 [TBL] [Abstract][Full Text] [Related]
9. Safety issues related to the use of recombinant DNA-derived cell culture products. I. Cellular components. Palladino MA; Levinson AD; Svedersky LP; Obijeski JF Dev Biol Stand; 1987; 66():13-22. PubMed ID: 3582742 [TBL] [Abstract][Full Text] [Related]
10. [Use of biotest systems in the assurance of biological safety]. Bykov VA; Denisov-Nikol'skiĭ IuI; Rebrov LB Vestn Ross Akad Med Nauk; 2002; (10):42-5. PubMed ID: 12428560 [No Abstract] [Full Text] [Related]
11. Recombinant microorganisms. Safety and regulatory aspects. Taylor AJ Bioprocess Technol; 1995; 22():383-406. PubMed ID: 7765536 [No Abstract] [Full Text] [Related]
12. Scale-up considerations and bioreactor development for animal cell cultivation. Tramper J; de Gooijer KD; Vlak JM Bioprocess Technol; 1993; 17():139-77. PubMed ID: 7763504 [No Abstract] [Full Text] [Related]
13. Ultra scale-down prediction using microwell technology of the industrial scale clarification characteristics by centrifugation of mammalian cell broths. Tait AS; Aucamp JP; Bugeon A; Hoare M Biotechnol Bioeng; 2009 Oct; 104(2):321-31. PubMed ID: 19507199 [TBL] [Abstract][Full Text] [Related]
14. Long-term cultivation of mammalian cells. Beyeler W; Thaler T; Clements R Am Biotechnol Lab; 1991 Oct; 9(9):28-9. PubMed ID: 1367561 [No Abstract] [Full Text] [Related]
15. [Problems of safety in biotechnology. Products of genetic engineering and regulation of work with them]. Vorob'ev AA; Chugasova VA; Korovkin VI Mol Gen Mikrobiol Virusol; 1987 Sep; (9):3-10. PubMed ID: 3323899 [No Abstract] [Full Text] [Related]
16. Safety in industrial microbiology and biotechnology: UK and European classifications of microorganisms and laboratories. Collins CH Trends Biotechnol; 1990 Dec; 8(12):345-8. PubMed ID: 1366895 [No Abstract] [Full Text] [Related]
17. Biotechnology and the environment. Science; 1987 Jun; 236(4806):1159-60. PubMed ID: 3589661 [No Abstract] [Full Text] [Related]
18. Developmental consequences of embryo and cell manipulation in mice and farm animals. McEvoy TG; Robinson JJ; Sinclair KD Reproduction; 2001 Oct; 122(4):507-18. PubMed ID: 11570957 [TBL] [Abstract][Full Text] [Related]
19. Raw materials as a source of contamination in large-scale cell culture. Garnick RL Dev Biol Stand; 1998; 93():21-9. PubMed ID: 9737373 [TBL] [Abstract][Full Text] [Related]
20. New disposable tubes for rapid and precise biomass assessment for suspension cultures of mammalian cells. Stettler M; Jaccard N; Hacker D; De Jesus M; Wurm FM; Jordan M Biotechnol Bioeng; 2006 Dec; 95(6):1228-33. PubMed ID: 16865737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]